News

A month has gone by since the last earnings report for Stratasys (SSYS). Shares have added about 6.8% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading

A month has gone by since the last earnings report for Red Robin (RRGB). Shares have added about 11.8% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

A month has gone by since the last earnings report for Brinker International (EAT). Shares have added about 0.6% in that time frame, underperforming the S&P 500.

Will the recent positive trend

It has been about a month since the last earnings report for Kodiak Sciences Inc. (KOD). Shares have lost about 1.2% in that time frame, underperforming the S&P 500.

Will the recent negative trend

A month has gone by since the last earnings report for Cisco Systems (CSCO). Shares have lost about 2.3% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

It has been about a month since the last earnings report for Allogene Therapeutics (ALLO). Shares have added about 9.4% in that time frame, outperforming the S&P 500.

Will the recent positive trend

Adobe ADBE reported third-quarter fiscal 2025 non-GAAP earnings of $5.31 per share, beating the Zacks Consensus Estimate by 2.71% and increasing 14.2% year over year.Total revenues were $5.99

Ashford Hospitality Trust AHT recently signed a definitive agreement to sell the 150-room Residence Inn San Diego Sorrento Mesa in San Diego, CA, for $42 million. Subject to closing conditions, the

Bloom Energy BE is well placed to benefit from the rapid growth in power demand fueled by artificial intelligence (“AI”) and large data centers. As AI workloads intensify, electricity needs will

Shares of Rapport Therapeutics RAPP surged 61.6% in a week after the company reported positive top-line data from a mid-stage study of its lead candidate, RAP-219, in patients with drug-resistant

Okta OKTA shares have appreciated 16.7% year to date (YTD), underperforming the Zacks Computer and Technology sector’s return of 18.2%. Okta’s shares can be attributed to slowing federal business, a

Verizon Communications Inc. VZ recently announced that the Tampa Police Department has formed a partnership with Verizon Frontline. The department has introduced the connected officer initiative

Vistra Corp. VST is currently trading at a premium valuation compared to its Zacks Utility Electric Power industry, with its forward 12-month price-to-earnings (P/E) ratio at 26.39X. The industry is

Globalstar, Inc. GSAT stock has been on a tear, gaining 37.3% in the past three months. While the gains are impressive, GSAT has underperformed the Satellite and Communication Industry, which is up

VICI Properties VICI boasts a high-quality portfolio of market-leading gaming, hospitality and entertainment destinations. Its mission-critical assets and long-term triple-net lease agreements with

Investors in Proficient Auto Logistics PAL need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $02.50 Call had some of the highest

An updated edition of the July 24, 2025 article.

The drone industry is witnessing rapid growth, with the global drone tech market expected to witness a CAGR of 14.3% from 2025 to 2030, according to

At the risk of under-selling it, this has been an eventful week. With key inflation data milder than many had expected and jobless claims surging week over week, the U.S. economy looks primed for an

Zacks Investment Research has initiated coverage of Security Federal Corporation SFDL with an “Outperform” recommendation, citing the company’s resilient fundamentals, solid earnings trajectory and

JetBlue Airways JBLU is expanding its Fort Lauderdale-Hollywood International Airport (FLL) operations, cementing its position as the number-one carrier with a record 113 peak daily departures this

Shares of Olema Pharmaceuticals OLMA have rallied 46.5% so far in September after the company announced a new collaboration agreement for its lead product candidate, palazestrant, with pharma bigwig

Investors in Pagaya Technologies, Ltd. PGY need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 01, 2026 $04.00 Put had some of the highest

Pfizer PFE has strengthened its R&D pipeline through M&A deals and clinical trial success over the past decade.

Pfizer has particularly advanced its oncology pipeline with several candidates